Biomarin Pharmaceutical Inc (BMRN)

Gross profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Gross profit	US$ in thousands	1,859,340	1,585,000	1,362,230	1,298,860	1,320,810
Revenue	US$ in thousands	2,374,190	2,068,670	1,832,750	1,823,140	1,680,280
Gross profit margin		78.31%	76.62%	74.33%	71.24%	78.61%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $1,859,340K ÷ $2,374,190K
= 78.31%

The gross profit margin of Biomarin Pharmaceutical Inc has shown a generally positive trend over the past five years, increasing from 78.61% in 2019 to 78.31% in 2023. This indicates that the company has been effectively managing its production costs and generating higher profits from its sales. The consistently high gross profit margin suggests that Biomarin Pharmaceutical Inc has a strong pricing strategy and efficient production processes in place. Overall, the company's ability to maintain a high gross profit margin reflects positively on its operational efficiency and profitability.